HEADER SIGNALING PROTEIN 27-AUG-13 4MF3 TITLE CRYSTAL STRUCTURE OF HUMAN GRIK1 COMPLEXED WITH A 6-(TETRAZOLYL)ARYL TITLE 2 DECAHYDROISOQUINOLINE ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR IONOTROPIC, KAINATE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 443-559 AND 682-822, EXTRACELLULAR DOMAINS; COMPND 5 SYNONYM: GLUK1, EXCITATORY AMINO ACID RECEPTOR 3, EAA3, GLUTAMATE COMPND 6 RECEPTOR 5, GLUR-5, GLUR5; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GRIK1, GLUR5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN-LIGAND COMPLEX, LIGAND GATED ION CHANNEL, GLUTAMATE RECEPTOR, KEYWDS 2 GLUTAMATE BINDING, NONE, MEMBRANE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.A.MARTINEZ-PEREZ,S.IYENGAR,H.E.SHANNON,D.BLEAKMAN,A.ALT, AUTHOR 2 D.K.CLAWSON,B.M.ARNOLD,M.G.BELL,T.J.BLEISCH,A.M.CASTANO,M.DEL PRADO, AUTHOR 3 E.DOMINGUEZ,A.M.ESCRIBANO,S.A.FILLA,K.H.HO,K.J.HUDZIAK,C.K.JONES, AUTHOR 4 M.A.KATOFIASC,A.MATEO,B.M.MATHES,E.L.MATTIUZ,A.M.L.OGDEN,L.A.PHEBUS, AUTHOR 5 R.M.A.SIMMONS,D.R.STACK,R.E.STRATFORD,M.A.WINTER,Z.WU,P.L.ORNSTEIN REVDAT 4 06-NOV-24 4MF3 1 REMARK SEQADV REVDAT 3 15-NOV-17 4MF3 1 REMARK REVDAT 2 26-JUL-17 4MF3 1 SOURCE REVDAT 1 07-MAY-14 4MF3 0 JRNL AUTH J.A.MARTINEZ-PEREZ,S.IYENGAR,H.E.SHANNON,D.BLEAKMAN,A.ALT, JRNL AUTH 2 D.K.CLAWSON,B.M.ARNOLD,M.G.BELL,T.J.BLEISCH,A.M.CASTANO, JRNL AUTH 3 M.DEL PRADO,E.DOMINGUEZ,A.M.ESCRIBANO,S.A.FILLA,K.H.HO, JRNL AUTH 4 K.J.HUDZIAK,C.K.JONES,A.MATEO,B.M.MATHES,E.L.MATTIUZ, JRNL AUTH 5 A.M.OGDEN,R.M.SIMMONS,D.R.STACK,R.E.STRATFORD,M.A.WINTER, JRNL AUTH 6 Z.WU,P.L.ORNSTEIN JRNL TITL GLUK1 ANTAGONISTS FROM 6-(TETRAZOLYL)PHENYL JRNL TITL 2 DECAHYDROISOQUINOLINE DERIVATIVES: IN VITRO PROFILE AND IN JRNL TITL 3 VIVO ANALGESIC EFFICACY. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 6463 2013 JRNL REFN ISSN 0960-894X JRNL PMID 24140446 JRNL DOI 10.1016/J.BMCL.2013.09.045 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 14975 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.238 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.040 REMARK 3 FREE R VALUE TEST SET COUNT : 755 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2671 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2802 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2510 REMARK 3 BIN R VALUE (WORKING SET) : 0.2763 REMARK 3 BIN FREE R VALUE : 0.3421 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.03 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 161 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4059 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 13 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 91.28 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.37370 REMARK 3 B22 (A**2) : -1.37370 REMARK 3 B33 (A**2) : 2.74730 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.506 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.918 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4198 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5680 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 4198 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 560 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4703 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.57 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.73 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MF3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081830. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97929 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24693 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.520 REMARK 200 RESOLUTION RANGE LOW (A) : 46.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.52 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN MIXED 1:1 WITH 55% MPD, 0.2M REMARK 280 NH4H2PO4, 0.1M TRIS PH 8.0, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.17733 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.58867 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.58867 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 73.17733 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 259 REMARK 465 GLU A 260 REMARK 465 GLY A 261 REMARK 465 GLU B 259 REMARK 465 GLU B 260 REMARK 465 GLY B 261 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 116 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 132 CG CD CE NZ REMARK 470 ARG A 165 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 TYR B 115 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 116 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 132 CG CD CE NZ REMARK 470 LYS B 157 CG CD CE NZ REMARK 470 ARG B 165 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU B 2 -33.39 -133.96 REMARK 500 ALA B 3 143.87 -174.14 REMARK 500 ARG B 5 153.48 166.48 REMARK 500 GLU B 14 117.96 -165.05 REMARK 500 ARG B 165 62.83 -100.95 REMARK 500 GLN B 167 -60.13 -92.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SXI A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SXI B 301 DBREF 4MF3 A 120 260 UNP P39086 GRIK1_HUMAN 682 822 DBREF 4MF3 A 1 119 UNP P39086 GRIK1_HUMAN 443 561 DBREF 4MF3 B 120 260 UNP P39086 GRIK1_HUMAN 682 822 DBREF 4MF3 B 1 119 UNP P39086 GRIK1_HUMAN 443 561 SEQADV 4MF3 GLY A 261 UNP P39086 EXPRESSION TAG SEQADV 4MF3 GLY B 261 UNP P39086 EXPRESSION TAG SEQRES 1 A 261 SER LEU ALA ASN ARG THR LEU ILE VAL THR THR ILE LEU SEQRES 2 A 261 GLU GLU PRO TYR VAL MET TYR ARG LYS SER ASP LYS PRO SEQRES 3 A 261 LEU TYR GLY ASN ASP ARG PHE GLU GLY TYR CYS LEU ASP SEQRES 4 A 261 LEU LEU LYS GLU LEU SER ASN ILE LEU GLY PHE ILE TYR SEQRES 5 A 261 ASP VAL LYS LEU VAL PRO ASP GLY LYS TYR GLY ALA GLN SEQRES 6 A 261 ASN ASP LYS GLY GLU TRP ASN GLY MET VAL LYS GLU LEU SEQRES 7 A 261 ILE ASP HIS ARG ALA ASP LEU ALA VAL ALA PRO LEU THR SEQRES 8 A 261 ILE THR TYR VAL ARG GLU LYS VAL ILE ASP PHE SER LYS SEQRES 9 A 261 PRO PHE MET THR LEU GLY ILE SER ILE LEU TYR ARG LYS SEQRES 10 A 261 GLY THR PRO ILE ASP SER ALA ASP ASP LEU ALA LYS GLN SEQRES 11 A 261 THR LYS ILE GLU TYR GLY ALA VAL ARG ASP GLY SER THR SEQRES 12 A 261 MET THR PHE PHE LYS LYS SER LYS ILE SER THR TYR GLU SEQRES 13 A 261 LYS MET TRP ALA PHE MET SER SER ARG GLN GLN THR ALA SEQRES 14 A 261 LEU VAL ARG ASN SER ASP GLU GLY ILE GLN ARG VAL LEU SEQRES 15 A 261 THR THR ASP TYR ALA LEU LEU MET GLU SER THR SER ILE SEQRES 16 A 261 GLU TYR VAL THR GLN ARG ASN CYS ASN LEU THR GLN ILE SEQRES 17 A 261 GLY GLY LEU ILE ASP SER LYS GLY TYR GLY VAL GLY THR SEQRES 18 A 261 PRO ILE GLY SER PRO TYR ARG ASP LYS ILE THR ILE ALA SEQRES 19 A 261 ILE LEU GLN LEU GLN GLU GLU GLY LYS LEU HIS MET MET SEQRES 20 A 261 LYS GLU LYS TRP TRP ARG GLY ASN GLY CYS PRO GLU GLU SEQRES 21 A 261 GLY SEQRES 1 B 261 SER LEU ALA ASN ARG THR LEU ILE VAL THR THR ILE LEU SEQRES 2 B 261 GLU GLU PRO TYR VAL MET TYR ARG LYS SER ASP LYS PRO SEQRES 3 B 261 LEU TYR GLY ASN ASP ARG PHE GLU GLY TYR CYS LEU ASP SEQRES 4 B 261 LEU LEU LYS GLU LEU SER ASN ILE LEU GLY PHE ILE TYR SEQRES 5 B 261 ASP VAL LYS LEU VAL PRO ASP GLY LYS TYR GLY ALA GLN SEQRES 6 B 261 ASN ASP LYS GLY GLU TRP ASN GLY MET VAL LYS GLU LEU SEQRES 7 B 261 ILE ASP HIS ARG ALA ASP LEU ALA VAL ALA PRO LEU THR SEQRES 8 B 261 ILE THR TYR VAL ARG GLU LYS VAL ILE ASP PHE SER LYS SEQRES 9 B 261 PRO PHE MET THR LEU GLY ILE SER ILE LEU TYR ARG LYS SEQRES 10 B 261 GLY THR PRO ILE ASP SER ALA ASP ASP LEU ALA LYS GLN SEQRES 11 B 261 THR LYS ILE GLU TYR GLY ALA VAL ARG ASP GLY SER THR SEQRES 12 B 261 MET THR PHE PHE LYS LYS SER LYS ILE SER THR TYR GLU SEQRES 13 B 261 LYS MET TRP ALA PHE MET SER SER ARG GLN GLN THR ALA SEQRES 14 B 261 LEU VAL ARG ASN SER ASP GLU GLY ILE GLN ARG VAL LEU SEQRES 15 B 261 THR THR ASP TYR ALA LEU LEU MET GLU SER THR SER ILE SEQRES 16 B 261 GLU TYR VAL THR GLN ARG ASN CYS ASN LEU THR GLN ILE SEQRES 17 B 261 GLY GLY LEU ILE ASP SER LYS GLY TYR GLY VAL GLY THR SEQRES 18 B 261 PRO ILE GLY SER PRO TYR ARG ASP LYS ILE THR ILE ALA SEQRES 19 B 261 ILE LEU GLN LEU GLN GLU GLU GLY LYS LEU HIS MET MET SEQRES 20 B 261 LYS GLU LYS TRP TRP ARG GLY ASN GLY CYS PRO GLU GLU SEQRES 21 B 261 GLY HET SXI A 301 26 HET SXI B 301 26 HETNAM SXI (3S,4AS,6S,8AR)-6-[3-CHLORO-2-(1H-TETRAZOL-5-YL) HETNAM 2 SXI PHENOXY]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID FORMUL 3 SXI 2(C17 H20 CL N5 O3) FORMUL 5 HOH *13(H2 O) HELIX 1 1 TYR A 28 ASP A 31 5 4 HELIX 2 2 GLY A 35 GLY A 49 1 15 HELIX 3 3 ASN A 72 ASP A 80 1 9 HELIX 4 4 THR A 93 LYS A 98 1 6 HELIX 5 5 SER A 123 LYS A 129 1 7 HELIX 6 6 GLY A 141 SER A 150 1 10 HELIX 7 7 ILE A 152 ARG A 165 1 14 HELIX 8 8 ARG A 165 ALA A 169 1 5 HELIX 9 9 ASN A 173 THR A 184 1 12 HELIX 10 10 SER A 192 GLN A 200 1 9 HELIX 11 11 PRO A 226 GLU A 241 1 16 HELIX 12 12 GLY A 242 ARG A 253 1 12 HELIX 13 13 TYR B 28 ASP B 31 5 4 HELIX 14 14 GLY B 35 GLY B 49 1 15 HELIX 15 15 ASN B 72 ASP B 80 1 9 HELIX 16 16 THR B 93 LYS B 98 1 6 HELIX 17 17 SER B 123 LYS B 129 1 7 HELIX 18 18 GLY B 141 SER B 150 1 10 HELIX 19 19 ILE B 152 SER B 163 1 12 HELIX 20 20 ASN B 173 THR B 184 1 12 HELIX 21 21 SER B 192 GLN B 200 1 9 HELIX 22 22 PRO B 226 GLU B 241 1 16 HELIX 23 23 GLY B 242 ARG B 253 1 12 SHEET 1 A 3 ILE A 51 LEU A 56 0 SHEET 2 A 3 THR A 6 THR A 11 1 N LEU A 7 O ILE A 51 SHEET 3 A 3 LEU A 85 ALA A 86 1 O LEU A 85 N THR A 10 SHEET 1 B 2 MET A 19 TYR A 20 0 SHEET 2 B 2 PHE A 33 GLU A 34 -1 O GLU A 34 N MET A 19 SHEET 1 C 2 ILE A 100 PHE A 102 0 SHEET 2 C 2 GLY A 220 PRO A 222 -1 O THR A 221 N ASP A 101 SHEET 1 D 2 MET A 107 LEU A 109 0 SHEET 2 D 2 LYS A 215 TYR A 217 -1 O LYS A 215 N LEU A 109 SHEET 1 E 5 LEU A 170 VAL A 171 0 SHEET 2 E 5 GLU A 134 VAL A 138 1 N ALA A 137 O VAL A 171 SHEET 3 E 5 TYR A 186 GLU A 191 1 O LEU A 189 N GLY A 136 SHEET 4 E 5 ILE A 111 ARG A 116 -1 N LEU A 114 O LEU A 188 SHEET 5 E 5 LEU A 205 ILE A 208 -1 O THR A 206 N TYR A 115 SHEET 1 F 3 TYR B 52 LEU B 56 0 SHEET 2 F 3 LEU B 7 THR B 11 1 N VAL B 9 O ASP B 53 SHEET 3 F 3 LEU B 85 ALA B 86 1 O LEU B 85 N THR B 10 SHEET 1 G 2 MET B 19 TYR B 20 0 SHEET 2 G 2 PHE B 33 GLU B 34 -1 O GLU B 34 N MET B 19 SHEET 1 H 2 ILE B 100 PHE B 102 0 SHEET 2 H 2 GLY B 220 PRO B 222 -1 O THR B 221 N ASP B 101 SHEET 1 I 2 MET B 107 LEU B 109 0 SHEET 2 I 2 LYS B 215 TYR B 217 -1 O LYS B 215 N LEU B 109 SHEET 1 J 4 GLU B 134 GLY B 136 0 SHEET 2 J 4 TYR B 186 GLU B 191 1 O LEU B 189 N GLY B 136 SHEET 3 J 4 ILE B 111 ARG B 116 -1 N LEU B 114 O LEU B 188 SHEET 4 J 4 LEU B 205 ILE B 208 -1 O THR B 206 N TYR B 115 SSBOND 1 CYS A 203 CYS A 257 1555 1555 2.04 SSBOND 2 CYS B 203 CYS B 257 1555 1555 2.04 CISPEP 1 GLU A 15 PRO A 16 0 -5.58 CISPEP 2 GLU B 15 PRO B 16 0 -6.69 SITE 1 AC1 11 TYR A 62 PRO A 89 LEU A 90 THR A 91 SITE 2 AC1 11 ARG A 96 THR A 143 SER A 174 MET A 190 SITE 3 AC1 11 GLU A 191 SER A 194 TYR A 217 SITE 1 AC2 9 TYR B 62 PRO B 89 THR B 91 ARG B 96 SITE 2 AC2 9 THR B 143 MET B 190 GLU B 191 SER B 194 SITE 3 AC2 9 TYR B 217 CRYST1 108.018 108.018 109.766 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009258 0.005345 0.000000 0.00000 SCALE2 0.000000 0.010690 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009110 0.00000